Cargando…

Homoarginine and Progression of Chronic Kidney Disease: Results from the Mild to Moderate Kidney Disease Study

BACKGROUND: Homoarginine is an amino acid derivative mainly synthesized in the kidney. It is suggested to increase nitric oxide availability, enhance endothelial function and to protect against cardiovascular diseases. We aimed to investigate the relation between homoarginine, kidney function and pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drechsler, Christiane, Kollerits, Barbara, Meinitzer, Andreas, März, Winfried, Ritz, Eberhard, König, Paul, Neyer, Ulrich, Pilz, Stefan, Wanner, Christoph, Kronenberg, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655120/ https://www.ncbi.nlm.nih.gov/pubmed/23691067 http://dx.doi.org/10.1371/journal.pone.0063560

Ejemplares similares

Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients
por: Drechsler, Christiane, et al.
Publicado: (2011)

Homoarginine—A prognostic indicator in adolescents and adults with complex congenital heart disease?
por: Raedle-Hurst, Tanja, et al.
Publicado: (2017)

Circulating Dopamine and C-Peptide Levels in Fasting Nondiabetic Hypertensive Patients: The Graz Endocrine Causes of Hypertension study
por: Tomaschitz, Andreas, et al.
Publicado: (2012)

The biomarker and causal roles of homoarginine in the development of cardiometabolic diseases: an observational and Mendelian randomization analysis
por: Seppälä, Ilkka, et al.
Publicado: (2017)

Association of relative telomere length with progression of chronic kidney disease in two cohorts: effect modification by smoking and diabetes
por: Raschenberger, Julia, et al.
Publicado: (2015)

Homoarginine/ADMA ratio and homoarginine/SDMA ratio as independent predictors of cardiovascular mortality and cardiovascular events in lower extremity arterial disease
por: Jud, Philipp, et al.
Publicado: (2018)

Homoarginine and Mortality in Pre-Dialysis Chronic Kidney Disease (CKD) Patients
por: Ravani, Pietro, et al.
Publicado: (2013)

l‐Homoarginine supplementation prevents diabetic kidney damage
por: Wetzel, Michael D., et al.
Publicado: (2019)

The association between parathyroid hormone and mortality in dialysis patients is modified by wasting
por: Drechsler, Christiane, et al.
Publicado: (2009)

Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients
por: Drechsler, Christiane, et al.
Publicado: (2010)

Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients
por: Drechsler, Christiane, et al.
Publicado: (2013)

Apolipoprotein A‐IV concentrations and clinical outcomes in a large chronic kidney disease cohort: Results from the GCKD study
por: Schwaiger, Johannes P., et al.
Publicado: (2022)

Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients
por: Winkler, Karl, et al.
Publicado: (2008)

Salt restriction in kidney disease—a missed therapeutic opportunity?
por: Ritz, Eberhard, et al.
Publicado: (2009)

Mineralocorticoid receptor blockade—a novel approach to fight hyperkalaemia in chronic kidney disease
por: Ritz, Eberhard, et al.
Publicado: (2013)

Creatine, guanidinoacetate and homoarginine in statin-induced myopathy
por: Neu, Axel, et al.
Publicado: (2020)

Influence of homoarginine on creatine accumulation and biosynthesis in the mouse
por: Lygate, Craig A., et al.
Publicado: (2022)

Lysine and homoarginine are closely interrelated metabolites in the rat
por: Baskal, Svetlana, et al.
Publicado: (2022)

Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses
por: Gaziano, Liam, et al.
Publicado: (2022)

Ecto-5' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients – Data from the German Calciphylaxis Registry
por: Rothe, Hansjörg, et al.
Publicado: (2017)

A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease
por: Schlackow, Iryna, et al.
Publicado: (2017)

Associations between genetic risk variants for kidney diseases and kidney disease etiology
por: Wunnenburger, Sebastian, et al.
Publicado: (2017)

Plasma Homoarginine Concentrations According to Use of Hormonal Contraception
por: Helm, Thea, et al.
Publicado: (2018)

Kidney outcome after mild to moderate COVID-19
por: Schmidt-Lauber, Christian, et al.
Publicado: (2023)

Heart Failure in a Cohort of Patients with Chronic Kidney Disease: The GCKD Study
por: Beck, Hanna, et al.
Publicado: (2015)

Bariatric surgery and the kidney—much benefit, but also potential harm
por: Ritz, Eberhard
Publicado: (2013)

Correction: Heart Failure in a Cohort of Patients with Chronic Kidney Disease: The GCKD Study
por: Beck, Hanna, et al.
Publicado: (2015)

Kidney function and symptom development over time in elderly patients with advanced chronic kidney disease: results of the EQUAL cohort study
por: Janmaat, Cynthia J, et al.
Publicado: (2020)

Mild and moderate pre-dialysis chronic kidney disease is associated with increased coronary artery calcium
por: Roy, Sion K, et al.
Publicado: (2011)

Mild to moderate chronic kidney disease and cardiovascular events in patients with type 2 diabetes mellitus
por: Lessey, Gayatri, et al.
Publicado: (2019)

Kidney manifestations of mild, moderate and severe coronavirus disease 2019: a retrospective cohort study
por: Hong, Daqing, et al.
Publicado: (2020)

Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild‐to‐Moderate Chronic Kidney Disease
por: Miller, Paul D, et al.
Publicado: (2022)

Low Homoarginine Levels in the Prognosis of Patients With Acute Chest Pain
por: Atzler, Dorothee, et al.
Publicado: (2016)

Population kinetics of homoarginine and optimized supplementation for cardiovascular risk reduction
por: Kleist, Christine J., et al.
Publicado: (2022)

Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients
por: Jan, Muhammad Y., et al.
Publicado: (2021)

Relation between Mild to Moderate Chronic Kidney Disease and Coronary Artery Disease Determined with Coronary CT Angiography
por: Joosen, Ivo A., et al.
Publicado: (2012)

Life/2020—the future of kidney disease
por: Stenvinkel, Peter, et al.
Publicado: (2020)

Immune Activation and Inflammation in Patients with Cardiovascular Disease Are Associated with Higher Phenylalanine to Tyrosine Ratios: The Ludwigshafen Risk and Cardiovascular Health Study
por: Murr, Christian, et al.
Publicado: (2014)

Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study
por: Schneider, Markus P., et al.
Publicado: (2018)

Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus
por: Müller, Michael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v3vhsan4nvingnq65cvhag3p2g